173 related articles for article (PubMed ID: 11456264)
1. A case of pulmonary metastatic thyroid cancer complicated with Graves' disease.
Suzuki K; Nakagawa O; Aizawa Y
Endocr J; 2001 Apr; 48(2):175-9. PubMed ID: 11456264
[TBL] [Abstract][Full Text] [Related]
2. A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma.
Ishihara T; Ikekubo K; Shimodahira M; Iwakura T; Kobayashi M; Hino M; Oobayashi M; Kohno K; Kimura K; Kawamura S; Kurahachi H
Endocr J; 2002 Apr; 49(2):241-5. PubMed ID: 12081245
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: report of three cases.
Misaki T; Iwata M; Kasagi K; Iida Y; Akamizu T; Kosugi S; Konishi J
Endocr J; 2000 Apr; 47(2):191-5. PubMed ID: 10943744
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating antibody in a patient with euthyroid Graves' disease.
Kubo T; Toki J; Kado Y; Kurihara M; Moriwake T; Kanzaki S; Seino Y
Endocr J; 2000 Apr; 47(2):197-201. PubMed ID: 10943745
[TBL] [Abstract][Full Text] [Related]
5. A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.
Aoyama M; Takizawa H; Tsuboi M; Nakagawa Y; Tangoku A
Endocr J; 2017 Dec; 64(12):1143-1147. PubMed ID: 28883260
[TBL] [Abstract][Full Text] [Related]
6. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
7. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
[TBL] [Abstract][Full Text] [Related]
8. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
9. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
Basaria S; Salvatori R
J Endocrinol Invest; 2002; 25(7):639-42. PubMed ID: 12150341
[TBL] [Abstract][Full Text] [Related]
10. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
Sato H
Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139
[TBL] [Abstract][Full Text] [Related]
13. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
14. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
16. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
17. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of Graves' disease and struma ovarii: case report and literature review.
Mimura Y; Kishida M; Masuyama H; Suwaki N; Kodama J; Otsuka F; Kataoka H; Yamauchi T; Ogura T; Kudo T; Makino H
Endocr J; 2001 Apr; 48(2):255-60. PubMed ID: 11456276
[TBL] [Abstract][Full Text] [Related]
19. Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.
Akuzawa M; Murakami M; Yamada M; Satoh T; Shimizu H; Mori M
Eur J Endocrinol; 1998 Mar; 138(3):281-5. PubMed ID: 9539302
[TBL] [Abstract][Full Text] [Related]
20. Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy.
Ryder M; Wentworth M; Algeciras-Schimnich A; Morris JC; Garrity J; Sanders J; Young S; Sanders P; Furmaniak J; Rees Smith B
Thyroid; 2021 Oct; 31(10):1597-1602. PubMed ID: 34114495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
